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Background
The incidence of malignant lymphomas (ML) in the
Western Cape, a province of South Africa (SA), with a
population of 5 million and an estimated HIV preva-
lence of 15% (census report 2002) has not been pre-
viously documented. Highly active antiretroviral therapy
(HAART) was introduced into the public patient sector
in 2004, with 28% estimated coverage by 2007
(UNAIDS/WHO 2008). People living with HIV (PLWH)
have 60-200 times increased risk of developing HIV-
related lymphoma (HRL). Therefore, based on HIV pre-
valence, HRL would be expected to increase but is
undocumented.
Materials and methods
We reviewed all patients diagnosed with ML from the
Tygerberg Academic Hospital catchments area in the
Western Cape of SA for years 2002-2009. In this time-
frame 606 cases of ML were identified, of which 488
were HIV-negative and 118 HIV-positive. ML were sub-
typed according to WHO classification (2008) based on
cell or tissue morphology and molecular and immuno-
phenotypic platforms.
Results
ML cases increased each year from 2002 to 2005 and
remain elevated in both the HIV-negative and HIV-posi-
tive patients through 2009. HRL increased from 5% in
2002 to 30% in 2009 with a profile of subtypes differing
from the HIV-negative cases. ML subtypes of HIV-nega-
tive (488) and HIV-positive (118) cases are shown in
Table 1.
Conclusions
ML cases increased from 2002 to 2009 including a dra-
matic increase in HRL, currently at 29% of all cases.
This changing pattern of subtypes in PLWH presents
new challenges to histopathology diagnosis as well as a
clinically more therapeutically difficult patient popula-
tion. Burkitt lymphoma, the most common HRL, is
among emerging subtypes, along with plasmablastic
lymphoma, not previously seen in this geographic
region. We anticipate the continued rise in HRL cases
as PLWH live longer with HAART. Emergence of more
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Table 1 Percentages of ML subtypes by HIV status.
Subtype %HIV- %HIV+
Burkitt lymphoma 35
Diffuse large B-cell lymphoma 44 33
Plasmablastic lymphoma 16
Follicular lymphoma 12
Hodgkin’s lymphoma 11 5
Small cell lymphoma 4 1
Mucosa-associated lymphoid tissue (MALT) 4 1
Anaplastic large cell lymphoma 3 3
Marginal zone lymphoma 3
Cutaneous T-cell lymphoma 3
T-cell lymphoma 2 1
Primary effusion lymphoma and Castleman’s disease 2
Other 13 4
Total 100 100
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© 2010 Ayers et al; licensee BioMed Central Ltd.aggressive lymphoma subtypes inevitably poses a major
strategic health concern in the region. We participate in
the Sub-Saharan Africa Lymphoma Consortium [http://
www.ssalc.org] to expand the understanding of HRL in
this region of the world.
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